Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Impact of Positive Airway Pressure Therapy on Health Care Resource Use in Patients With OSA and Coronary Artery
Peter A Cistulli1, Anita S Malik2, Adam V Benjafield3
1Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
Insights
Adhering to positive airway pressure (PAP) therapy for obstructive sleep apnea (OSA) in coronary artery disease (CAD) patients significantly reduces healthcare costs. Even minimal nightly use shows benefits, highlighting the importance of OSA treatment.
Area of Science:
- Cardiology
- Pulmonology
- Health Services Research
Background:
- Obstructive sleep apnea (OSA) is a known risk factor for coronary artery disease (CAD).
- The impact of positive airway pressure (PAP) therapy adherence on healthcare resource utilization (HCRU) in patients with both CAD and OSA is not well understood.
Purpose of the Study:
- To investigate whether adherence to PAP therapy is associated with reduced HCRU in patients diagnosed with both CAD and OSA.
- To quantify the relationship between PAP adherence and healthcare utilization outcomes.
Main Methods:
- Retrospective analysis of administrative claims linked with objective PAP usage data.
- Included adults (≥18 years) with CAD and newly diagnosed OSA.
- Two-year adherence defined by 90-day intervals; inverse probability of treatment weighting used to assess ER visits and hospitalizations.
Main Results:
- 32,911 patients included; adherent patients had significantly fewer ER visits (-24% to -26%) and hospitalizations (-35% to -39%) compared to nonadherent patients.
- Intermediate adherence correlated with HCRU between adherent and nonadherent groups.
- Minimum nightly PAP use <3 hours/night yielded significant HCRU benefits; each additional hour reduced HCRU by 4.7%-5.9%.
Conclusions:
- PAP therapy adherence is linked to lower HCRU in real-world patients with CAD and newly diagnosed OSA.
- These findings underscore the clinical and economic importance of diagnosing and treating OSA in patients with CAD.
Background:
OSA is associated with coronary artery disease (CAD) risk. This study examined the impact of positive airway pressure (PAP) therapy adherence on health care resource use (HCRU) in patients with CAD and newly diagnosed OSA.
Research Question:
Is adherence to PAP therapy associated with reduced HCRU in patients with CAD and OSA?
Study Design And Methods:
This retrospective analysis linked administrative claims to objective PAP use data (ResMed AirView) for adults (≥ 18 years of age) with CAD who received a new diagnosis of OSA. Two-year adherence was defined by the number of 90-day time frames in which adherence criteria were met. Inverse probability of treatment weighting was applied to assess primary outcomes of emergency room (ER) visits and hospitalizations 1 and 2 years after the index date.
Results:
Thirty-two thousand nine hundred eleven patients were included (34.9% female; mean age, 60.9 years). Compared with adherent patients, nonadherent patients were slightly younger, more commonly female, and had higher prevalence of severe obesity and comorbidities. Compared with nonadherent patients, adherent patients made significantly fewer ER visits (-26% and -24%; P < .001) and all-cause hospitalizations (-35% and -39%; P < .001) in years 1 and 2, respectively. HCRU for intermediately adherent patients fell between that of adherent and nonadherent patients. After risk adjustment, the threshold for minimum nightly PAP use to derive a significant HCRU benefit was < 3 h/night for all outcomes and periods. A 4.7% to 5.9% reduction in HCRU rates with each additional hour per night of PAP use was noted.
Interpretation:
In real-world patients with CAD and newly diagnosed OSA, PAP therapy adherence was associated with lower HCRU. These findings strongly support the importance of diagnosing and treating OSA in these patients.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cardiopulmonary Resuscitation II: ACLS Airway Management
COPD: Management Using Bronchodilators and Corticosteroids

